STERIS has hygiene hysteria. The company makes sterilization systems for health care, pharmaceutical, research, and industrial markets. In addition to the company's sanitizing lotions and soaps, health care professionals use the firm's steam and chemical sterilization systems to sterilize surgical and diagnostic devices. STERIS also makes disinfection systems and infection prevention consumables. The company sells such surgical support products as exam lights, surgical tables, and scrub sinks. STERIS sells its equipment and consumables in more than 60 countries. In North America, its Isomedix unit offers contract sterilization for more than a dozen health care, industrial, and consumer products makers.
Products sold in the US market account for three-fourths of STERIS' sales. The company has contract sterilization, manufacturing, and warehouse locations throughout the US, as well as in Canada, Mexico, Brazil, France, Finland, and the UK.
Sales and Marketing
The company's US offerings are marketed to hospitals and surgery centers through STERIS' direct sales force. International sales are conducted through direct sales offices in Brazil, Canada, China, France, Germany, India, Italy, Japan, Malaysia, Russia, Singapore, Spain, the UAE, and the UK, as well as through representative distributors in other countries. The company's life sciences segment markets sterilization products to customers in the pharmaceutical and research industries.
STERIS is continually working to develop new and improved products to enhance its offerings, including new chemical agents, disinfection and sterilization systems, and surgical equipment. It also looks to grow through partnership and acquisition opportunities.
Shortly after announcing a restructuring plan in 2014 that included closing its Mentor, Ohio, facility that made a discontinued product, STERIS bought Integrated Medical Systems (IMS), a surgical instrument repair, sterilization, and maintenance firm for an undisclosed amount.
Mergers and Acquisitions
In 2015 STERIS became the latest US company to make a purchase aimed, at least partially, at reducing its tax burden. It acquired UK-based Synergy Health, an outsourced medical instrument sterilization company, for nearly $2 billion. The move allows STERIS to avoid US corporate taxes. The following year, STERIS sold UK Linen Management Services, acquired as part of the Synergy Health deal, to STAR Mayan for $66.5 million.